📋 Key Insights for Retailers
- 280E relief is selective. Tax benefits primarily follow the “medical lane.” Adult-use sales may remain restricted without clear operational separation.
- Banking won’t flip overnight. While risk profiles improve, national banks and credit card networks are waiting for formal FinCEN guidance before changing policies.
- Interstate commerce is still a “no.” Schedule III does not authorize moving products across state lines; markets remain state-siloed.
- Compliance is the priority. Rescheduling may actually increase federal documentation requirements for those seeking medical tax status.
Acting Attorney General Todd Blanche’s unilateral April 23 order moved medical marijuana and qualifying state-licensed businesses into Schedule III — a significant federal shift that could change the tax math, banking conversations, and financing environment for dispensaries. But only for some of them, and not all at once.
For Jason Harris, that tension is personal. The glass artist and founder of Jerome Baker Designs watched federal agents raid his shop thirty years ago. “Today, they’re starting to admit they were wrong,” he said, “but not all the way.”
Not all the way turns out to be a precise description of what the order actually does — and doesn’t do. It is meaningful, but it does not mean dispensaries can relax. The operators who handle this moment best probably will be the ones who treat it as an opportunity for sorting, not celebrating.
280E: all sales are not exempt
The most immediate issue is Internal Revenue Code Section 280E.
Since the dawn of the legal market, dispensaries have operated under one of the industry’s harshest distortions: a 1982 federal tax rule that prevents businesses trafficking in Schedule I or II substances from deducting ordinary operating expenses. That is why so many cannabis retailers have lived with warped effective tax rates and unusually thin room for margin error.
If your dispensary is operating inside a qualifying medical lane covered by the April 23 order, that could change in a very real way. The possibility of deducting ordinary business expenses is not a headline flourish. It is a margin event. Rent, payroll, marketing, software, and store operations all look different when the tax code starts treating them more like ordinary business costs.
That is the upside everyone is seeing, and for good reason.
“For years, dispensaries have been taxed in an unsustainable way under 280E, unable to deduct basic business expenses like rent, payroll, and marketing that every other retailer in America takes for granted,” said Thomas Sheridan, chief executive officer at MWG Holdings Group Inc., parent company of retailer Perfect Union. “The tax relief [rescheduling] unlocks is real, it is immediate, and it could be the difference between survival and closure for small and mid-sized operators who have been fighting just to keep their doors open.”
But this next truth matters just as much: Not every dispensary will receive that benefit equally, and not every dispensary gets it now.
For adult-use operators, the simple story that “280E is gone” is too broad. If you run a mixed business offering both medical and adult-use products, the issue becomes operational. You may need a much cleaner separation between covered and non-covered activity than you have today. Revenue mapping, store-level documentation, entity structure, and recordkeeping discipline all suddenly matter more than ever.
That means now is not the time to make aggressive assumptions. Now is the time to sit down with tax counsel, finance leadership, and the compliance team and ask a narrower question: “What part of my operation is inside the newly covered lane, and what proof will I need if that treatment is challenged later?”
According to GCNC Holdings CEO Chris Day, “There are a lot of processes and rules to be implemented still. Schedule III is certainly favorable for large pharmaceutical companies and MSOs, but there are a lot of outstanding questions around what this will mean for the thousands of smaller and mid-size operators across the country.”
💡 Action Step: The “Revenue Split” Audit
How to Prepare Your Books for 280E Relief
To benefit from Schedule III, you must prove which portion of your business qualifies for federal tax deductions. Don’t wait for an audit to start this process:
- Separate the ledger: Work with your POS provider to create distinct reporting tags for “medical-qualifying” vs. “adult-use” transactions.
- Document square footage: If your state allows co-located facilities, document the physical space dedicated to medical consultations or storage to justify a pro-rata deduction of rent and utilities.
- Time-track labor: Have staff log hours specifically dedicated to medical-patient care or administrative tasks related to Schedule III compliance.
Banking: no quick fixes
The banking question is similar.
Yes, rescheduling could make banking conversations easier. If cannabis is no longer sitting entirely in the most restrictive federal category, some financial institutions may become more comfortable revisiting relationships with businesses in the sector. Lenders, insurers, payment providers, and deposit partners all may see a lower perceived risk profile over time.
But “over time” is the operative phrase in that sentence.
Banks do not change behaviors because operators want them to, or even because an industry sector’s federal status evolves. They change behaviors when their own compliance teams, examiners, counterparties, and risk models are comfortable with new conditions. Rescheduling does not instantly erase suspicious-activity expectations, internal policy limits, underwriting caution, or the reality that adult-use cannabis still sits in a legally awkward place. A few conversations may open faster, but that is not the same as the whole channel normalizing.
“If financial institutions begin to adopt a more practical approach to state-licensed cannabis operators, that could create a more stable and sustainable business environment in the years ahead,” said Jimmy Brinkerhoff, co-founder and CEO at Edun.
For dispensaries, the practical banking takeaway is simple: Test the new tone, but do not base a near-term operating plan on instant access to cheaper capital, mainstream card acceptance, or dramatically broader financial services.
Compliance: new federal rules may add to the burden
Compliance may be the most misunderstood aspect of rescheduling’s consequences.
Rescheduling does not replace state regulations. It does not remove store security obligations, testing rules, labeling standards, packaging controls, marketing restrictions, inventory tracking, or age-verification procedures. Dispensaries are still state-regulated businesses operating inside a strictly controlled system.
In fact, the compliance burden may increase for some operators, because Schedule III’s federal requirements may add even more formal structure. If your business wants to claim the benefits of the new medical lane, then documentation, registration posture, and operational separation will become more important, not less.
“Let’s be crystal clear: This is not recreational legalization,” said Howard Kessler, founder of The Commonwealth Project. “Medical cannabis must stay in its own lane — prescribed, studied, monitored, and covered like any other legitimate therapy.”
The dispensaries that benefit most will be the ones already running precise books, disciplined standard operating procedures, and defensible distinctions between medical and adult-use activity.
So, what should dispensaries do now?
First, identify whether your revenue is purely medical, purely adult-use, or mixed. If the answer is the latter, determine how clearly the lines are drawn in your reporting.
Second, review your entity and accounting structure. If 280E treatment may change for part of the business, make sure your books clearly show the dividing line. The 280E-exempt part of the business must be crystal clear.
Third, reopen banking conversations, but as a fact-finding exercise, not a victory lap. Ask what your current bank, prospective lenders, payment providers, and insurance partners are changing, if anything, in response to medical cannabis’s reclassification to Schedule III.
Fourth, tell store leadership not to improvise. No one should assume rescheduling changes what can be sold, how it can be sold, or whether compliance rules may be relaxed at the register.
Finally, watch guidance, not vibes. Treasury Department and Internal Revenue Service interpretation, broader hearing outcomes, and regulator behavior will decide how much of the rescheduling promise turns into usable operating relief.
“We need the [Drug Enforcement Administration] to act swiftly to finalize rescheduling and provide the regulatory certainty that businesses, investors, and consumers have wanted for so long,” said Bonanza Cannabis Company co-owner Corey Keller.
The takeaway
This is the real dispensary takeaway: Rescheduling is important because it may finally change some of the industry’s worst business math. But the stores that score wins will not treat medical rescheduling like a blanket green light. They will use the next few weeks to get more precise about taxes, more realistic about banking, and batten down compliance even tighter.
That may not be the flashy version of the story, but it is likely the profitable one. And as Sunderstorm CEO Cameron Clarke noted, “When retailers are profitable, the entire supply chain strengthens.”
Frequently Asked Questions
1. Does Schedule III eliminate 280E taxes for all dispensaries?
Not necessarily. Under current interpretations, 280E relief specifically follows the federal “medical” reclassification. Adult-use retailers may still face 280E restrictions unless they can clearly document and partition their medical-related revenue and operations.
2. When will my bank start accepting cannabis credit card payments?
Rescheduling is a signal, not a mandate for banks. While it lowers the perceived risk profile, major card networks (Visa/Mastercard) and national banks typically will wait for formal guidance from FinCEN or the passage of the SAFER Banking Act before fully opening credit card processing.
3. Will Schedule III allow for interstate commerce?
No. Rescheduling does not authorize the movement of cannabis products across state lines. State-licensed markets remain “islands” for now, as interstate commerce falls under separate federal jurisdiction and Department of Justice enforcement priorities.
4. Do I need a new license to operate under Schedule III?
Your state license remains your primary authorization. However, to benefit from federal medical recognition, you may eventually need to register with the DEA or follow new FDA-aligned documentation standards that are still being finalized.
